Glomerular Diseases: 2025 Update

Online Product

Glomerular medicine is exploding with exciting new understanding of disease pathogenesis, which has led to developments in novel genetic and serological diagnostic tools, clinical trials, and potential new treatments. In this program, a panel of experts discusses these advances in the form of comprehensive updates and case-based discussions (adult and pediatric) with time for audience questions. This program explores novel changes in our favorites: IgA nephropathy, lupus nephritis, podocytopathies (FSGS/minimal change disease [MCD]), ANCA-associated vasculitis, membranous glomerulonephritis, complement in kidney disease, and monoclonal gammopathies of renal significance. Hot topics are also addressed, including how and when to use genetics in the diagnosis and treatment of glomerular diseases, type IV collagen-related diseases, and anticipated uses of artificial intelligence (AI) in the diagnosis of glomerular diseases. Participants learn about cutting-edge clinical applications in treatment, pathology, and genetics that continue to change the diagnostic and therapeutic landscape in glomerular medicine. Please note: no CE credit is available for this On-Demand product. Support for this Early Program is provided by an educational grant from Vera Therapeutics, Inc.